U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C10H8OS3
Molecular Weight 240.3685
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ANETHOLTRITHION

SMILES

COc1ccc(cc1)-c2cc(=S)ss2

InChI

InChIKey=KYLIZBIRMBGUOP-UHFFFAOYSA-N
InChI=1S/C10H8OS3/c1-11-8-4-2-7(3-5-8)9-6-10(12)14-13-9/h2-6H,1H3

HIDE SMILES / InChI

Molecular Formula C10H8OS3
Molecular Weight 240.3685
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment:: https://www.ncbi.nlm.nih.gov/pubmed/19957670

Anethole trithione or anetholtrithione is a drug used in the treatment of dry mouth. Anethole trithione is a bile secretion-stimulating drug that restores salivation. It is listed in the U.S. National Cancer Institute's Dictionary of Cancer Terms as being studied in the treatment of cancer. Anethol has also been identified as a treatment for improving medium and severe dry eye symptoms. The mechanism of action for the chemopreventive and xerostomia properties have not been fully elucidated.

CNS Activity

Curator's Comment:: Known to be CNS NON-penetrant in mouse. Human data not available.

Approval Year

PubMed

PubMed

TitleDatePubMed
Synergistic effect of sialagogues in management of xerostomia after radiation therapy.
1987 Aug
Assessment of the role of glutathione conjugation in the protection afforded by anethol dithiolthione against hexachloro-1,3-butadiene-induced nephrotoxicity.
1996 Jul
Lens epithelial cell protection by aminothiol WR-1065 and anetholedithiolethione from ionizing radiation.
2001
Seizures in the developing brain.
2004
HPLC determination of 4-hydroxy-anethole trithione in plasma via enzymatic hydrolysis and its application to bioequivalence study.
2008 Jul 15
[The clinical therapic efficiency of anethol trithione on dry eye].
2009 Jun
Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.
2010 May
Modulation of thiol homeostasis induced by H2S-releasing aspirin.
2010 May 1
Patents

Patents

Sample Use Guides

was administered 6 tablets per day
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Jun 26 09:12:59 UTC 2021
Edited
by admin
on Sat Jun 26 09:12:59 UTC 2021
Record UNII
QUY32964DJ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ANETHOLTRITHION
JAN  
Common Name English
OP2113
Code English
ANETHOLE TRITHIONE [MART.]
Common Name English
OP-2113
Code English
ANETHOLE TRITHIONE [MI]
Common Name English
ANETHOLE TRITHIONE [WHO-DD]
Common Name English
5-(P-METHOXYPHENYL)-3H-1,2-DITHIOLE-3-THIONE
Common Name English
ANETHOLTRITHION [JAN]
Common Name English
ANETHOLE TRITHIONE
MART.   MI   WHO-DD  
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C54630
Created by admin on Sat Jun 26 09:12:59 UTC 2021 , Edited by admin on Sat Jun 26 09:12:59 UTC 2021
WHO-ATC A16AX02
Created by admin on Sat Jun 26 09:12:59 UTC 2021 , Edited by admin on Sat Jun 26 09:12:59 UTC 2021
WHO-VATC QA16AX02
Created by admin on Sat Jun 26 09:12:59 UTC 2021 , Edited by admin on Sat Jun 26 09:12:59 UTC 2021
Code System Code Type Description
PUBCHEM
2194
Created by admin on Sat Jun 26 09:12:59 UTC 2021 , Edited by admin on Sat Jun 26 09:12:59 UTC 2021
PRIMARY
MERCK INDEX
M1907
Created by admin on Sat Jun 26 09:12:59 UTC 2021 , Edited by admin on Sat Jun 26 09:12:59 UTC 2021
PRIMARY Merck Index
ChEMBL
CHEMBL178862
Created by admin on Sat Jun 26 09:12:59 UTC 2021 , Edited by admin on Sat Jun 26 09:12:59 UTC 2021
PRIMARY
ECHA (EC/EINECS)
208-528-5
Created by admin on Sat Jun 26 09:12:59 UTC 2021 , Edited by admin on Sat Jun 26 09:12:59 UTC 2021
PRIMARY
FDA UNII
QUY32964DJ
Created by admin on Sat Jun 26 09:12:59 UTC 2021 , Edited by admin on Sat Jun 26 09:12:59 UTC 2021
PRIMARY
EPA CompTox
532-11-6
Created by admin on Sat Jun 26 09:12:59 UTC 2021 , Edited by admin on Sat Jun 26 09:12:59 UTC 2021
PRIMARY
CAS
532-11-6
Created by admin on Sat Jun 26 09:12:59 UTC 2021 , Edited by admin on Sat Jun 26 09:12:59 UTC 2021
PRIMARY
DRUG BANK
DB13853
Created by admin on Sat Jun 26 09:12:59 UTC 2021 , Edited by admin on Sat Jun 26 09:12:59 UTC 2021
PRIMARY
MESH
D000781
Created by admin on Sat Jun 26 09:12:59 UTC 2021 , Edited by admin on Sat Jun 26 09:12:59 UTC 2021
PRIMARY
RXCUI
820
Created by admin on Sat Jun 26 09:12:59 UTC 2021 , Edited by admin on Sat Jun 26 09:12:59 UTC 2021
PRIMARY RxNorm
NCI_THESAURUS
C246
Created by admin on Sat Jun 26 09:12:59 UTC 2021 , Edited by admin on Sat Jun 26 09:12:59 UTC 2021
PRIMARY
EVMPD
SUB12902MIG
Created by admin on Sat Jun 26 09:12:59 UTC 2021 , Edited by admin on Sat Jun 26 09:12:59 UTC 2021
PRIMARY
DRUG CENTRAL
218
Created by admin on Sat Jun 26 09:12:59 UTC 2021 , Edited by admin on Sat Jun 26 09:12:59 UTC 2021
PRIMARY
Related Record Type Details
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
MINOR
Related Record Type Details
METABOLITE -> PARENT
METABOLITE -> PARENT
METABOLITE -> PARENT
METABOLITE -> PARENT
METABOLITE -> PARENT
METABOLITE -> PARENT
MAJOR
METABOLITE -> PARENT
Related Record Type Details
ACTIVE MOIETY